Literature DB >> 22921433

Early and late neurodegeneration and memory disruption after intracerebroventricular streptozotocin.

Taisa Oliveira Santos1, Caio Henrique Yokoyama Mazucanti, Gilberto Fernando Xavier, Andréa Silva Torrão.   

Abstract

Glucose metabolism and insulin signaling disruptions in the brain have been proposed as a likely etiology of Alzheimer's disease. The aim of the present study was to investigate the time course of cognitive impairments induced by intracerebroventricular injection of streptozotocin (STZ) in rats and correlate them with the ensuing neurodegenerative process. Early and late effects of STZ were evaluated by using the reference and working memory versions of the Morris' water maze task and the evaluation of neurodegenerative markers by immunoblotting and the Fluoro-Jade C histochemistry. The results revealed different types of behavioral and neurodegenerative responses, with distinct time courses. We observed an early disruption on the working memory as early as 3h after STZ injections, which was followed by degenerative processes in the hippocampus at 1 and 15 days after STZ injections. Memory disruption increases over time and culminates with significant changes in amyloid-beta peptide and hyperphosphorylated Tau protein levels in distinct brain structures. These findings add information on the Alzheimer's disease-like STZ animal model and on the mechanisms underlying neurodegenerative processes.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22921433     DOI: 10.1016/j.physbeh.2012.06.019

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  20 in total

1.  Captopril and Valsartan May Improve Cognitive Function Through Potentiation of the Brain Antioxidant Defense System and Attenuation of Oxidative/Nitrosative Damage in STZ-Induced Dementia in Rat.

Authors:  Yasaman Arjmand Abbassi; Mohammad Taghi Mohammadi; Mahsa Sarami Foroshani; Javad Raouf Sarshoori
Journal:  Adv Pharm Bull       Date:  2016-12-22

Review 2.  Food for thought: the role of appetitive peptides in age-related cognitive decline.

Authors:  Jim R Fadel; Corinne G Jolivalt; Lawrence P Reagan
Journal:  Ageing Res Rev       Date:  2013-02-13       Impact factor: 10.895

3.  Rat brain glucose transporter-2, insulin receptor and glial expression are acute targets of intracerebroventricular streptozotocin: risk factors for sporadic Alzheimer's disease?

Authors:  A Knezovic; A Loncar; J Homolak; U Smailovic; J Osmanovic Barilar; L Ganoci; N Bozina; P Riederer; Melita Salkovic-Petrisic
Journal:  J Neural Transm (Vienna)       Date:  2017-05-03       Impact factor: 3.575

4.  Staging of cognitive deficits and neuropathological and ultrastructural changes in streptozotocin-induced rat model of Alzheimer's disease.

Authors:  Ana Knezovic; Jelena Osmanovic-Barilar; Marija Curlin; Patrick R Hof; Goran Simic; Peter Riederer; Melita Salkovic-Petrisic
Journal:  J Neural Transm (Vienna)       Date:  2015-03-26       Impact factor: 3.575

5.  Nine-month follow-up of the insulin receptor signalling cascade in the brain of streptozotocin rat model of sporadic Alzheimer's disease.

Authors:  J Osmanovic Barilar; A Knezovic; E Grünblatt; P Riederer; M Salkovic-Petrisic
Journal:  J Neural Transm (Vienna)       Date:  2014-12-12       Impact factor: 3.575

6.  Intracerebroventricular Streptozotocin as a Model of Alzheimer's Disease: Neurochemical and Behavioral Characterization in Mice.

Authors:  Katherine Garcia Ravelli; Barbara Dos Anjos Rosário; Rosana Camarini; Marina Sorrentino Hernandes; Luiz Roberto Britto
Journal:  Neurotox Res       Date:  2016-12-02       Impact factor: 3.911

7.  Quercetin Exhibits α7nAChR/Nrf2/HO-1-Mediated Neuroprotection Against STZ-Induced Mitochondrial Toxicity and Cognitive Impairments in Experimental Rodents.

Authors:  Niraj Kumar Singh; Debapriya Garabadu
Journal:  Neurotox Res       Date:  2021-09-23       Impact factor: 3.911

8.  MA-[D-Leu-4]-OB3, a small molecule synthetic peptide leptin mimetic, improves episodic memory, and reduces serum levels of tumor necrosis factor-alpha and neurodegeneration in mouse models of Type 1 and Type 2 Diabetes Mellitus.

Authors:  Zall Hirschstein; Gautam Reddy Vanga; Guirong Wang; Zachary M Novakovic; Patricia Grasso
Journal:  Biochim Biophys Acta Gen Subj       Date:  2020-07-29       Impact factor: 3.770

9.  Taurine ameliorates neurobehavioral, neurochemical and immunohistochemical changes in sporadic dementia of Alzheimer's type (SDAT) caused by intracerebroventricular streptozotocin in rats.

Authors:  Hayate Javed; Andleeb Khan; Kumar Vaibhav; Mohd Moshahid Khan; Ajmal Ahmad; Md Ejaz Ahmad; Ashafaq Ahmad; Rizwana Tabassum; Farah Islam; Mohammed M Safhi; Fakhrul Islam
Journal:  Neurol Sci       Date:  2013-05-17       Impact factor: 3.307

10.  Intracerebral Injection of Streptozotocin to Model Alzheimer Disease in Rats.

Authors:  Daniel Moreira-Silva; Robson C L Vizin; Talita M S Martins; Tatiana L Ferreira; Maria C Almeida; Daniel C Carrettiero
Journal:  Bio Protoc       Date:  2019-10-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.